Get it on Google Play

Definium to present Phase 3 DT120 trial data at Psych Congress 2026

September 10, 2026 7:00 AM EDT Send to a Friend
Definium Therapeutics (Nasdaq: DFTX) announced it will present six poster presentations at Psych Congress, taking place September 15 through 19 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login